otu2 Antibody

Definition and Biological Role of OTUB2

OTUB2 is a member of the OTU (ovarian tumor) deubiquitinase family, encoded by the OTUB2 gene (HGNC: 20351, UniProt: Q96DC9). It hydrolyzes ubiquitin-protein conjugates, preferentially cleaving Lys63-linked polyubiquitin chains, and stabilizes substrates like PD-L1 in cancer cells . OTUB2 is implicated in:

• Immune evasion: Stabilizing PD-L1 to suppress CD8+ T-cell cytotoxicity .

• Cancer progression: Promoting tumor growth via Hippo, AKT/mTOR, and NF-κB signaling pathways .

• Ribosome recycling: Assisting in 40S ribosomal subunit maturation and translation reset .

Cancer Immunology

• PD-L1 Regulation: OTUB2 antibodies validated OTUB2’s role in stabilizing PD-L1 by blocking its ubiquitination in the endoplasmic reticulum. Knockdown of OTUB2 reduced PD-L1 surface expression, enhancing CD8+ T-cell-mediated tumor killing .

• Clinical Correlation: In non-small cell lung cancer (NSCLC), OTUB2 expression inversely correlates with CD8+ T-cell infiltration and patient survival .

Drug Development

• OTUB2 Inhibitors: Antibodies aided in characterizing OTUB2-IN-1, a small-molecule inhibitor that reduces PD-L1 levels and suppresses tumor growth in preclinical models .

Western Blot (WB)

• Proteintech (12066-1-AP): Detects OTUB2 at ~27 kDa in mouse and rat testis lysates .

• Sigma-Aldrich (SAB1407928): Validated for human samples with a working concentration of 1 µg/mL .

Immunofluorescence (IF)

• Proteintech (12066-1-AP): Localizes OTUB2 to the cytoplasm in U2OS cells .

Key Research Insights

• Mechanistic Role: OTUB2 stabilizes PD-L1 by counteracting endoplasmic reticulum-associated degradation (ERAD), making it a therapeutic target for immune checkpoint blockade .

• Disease Linkage: High OTUB2 expression correlates with poor prognosis in lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) .

Limitations and Future Directions

• Antibody Specificity: Some antibodies lack cross-reactivity validation beyond human/mouse/rat .

• Therapeutic Challenges: OTUB2 inhibitors like OTUB2-IN-1 require further pharmacokinetic studies for clinical translation .